
Indiana Legislature Passes Hemp THC Restrictions Amid Federal Ban
New bill aligns state regulations with federal synthetic cannabinoid restrictions
Indiana lawmakers advanced legislation this week to restrict and regulate intoxicating hemp-derived products, marking the state's response to recent federal action banning synthetic cannabinoids.
The bill aims to clarify regulatory uncertainty around delta-8 THC and similar hemp-derived intoxicants that have proliferated in states without adult-use cannabis programs. "We'd just like, in Indiana, some certainty as to these products so that the people manufacturing and selling them know kind of what our laws are," one lawmaker told the Indiana Capital Chronicle.
The legislation follows the federal government's recent move to ban synthetic and intoxicating hemp products—a decision that caught many state regulators off guard. Indiana's bill would bring state law into alignment with those federal restrictions, though specific enforcement mechanisms remain under discussion.
The Hemp Loophole Problem
The issue stems from the 2018 Farm Bill, which legalized hemp containing less than 0.3% delta-9 THC. That created a massive gray market for chemically converted cannabinoids like delta-8 THC, which can be synthesized from legal CBD.
These products—sold as gummies, vapes, and tinctures—have become ubiquitous in gas stations and smoke shops across prohibition states. Industry analysts estimate the unregulated hemp-derived THC market reached $2 billion in sales last year.
But the rapid growth came with minimal oversight. Products often lack testing requirements, age verification, or potency limits that apply to state-regulated cannabis programs. Public health officials in multiple states have raised concerns about contamination and mislabeling.
Industry Pushback
The Indiana legislation faced opposition from hemp industry stakeholders who argue the restrictions go too far. Hemp retailers and manufacturers have built businesses around these products in the absence of legal cannabis access.
Critics of the bill say it could eliminate consumer access to hemp-derived cannabinoids that many use for wellness purposes. The hemp industry has lobbied aggressively against similar restrictions in other states, arguing for age limits and testing rather than outright bans.
Indiana remains one of 12 states with no legal cannabis program of any kind—neither medical nor adult-use. That's made hemp-derived products the only legal option for consumers seeking cannabinoid effects.
What Happens Next
The bill now moves to the governor's desk for signature. If enacted, Indiana would join a growing list of states tightening hemp regulations after years of largely ignoring the market.
At least 15 states have passed or proposed similar legislation in the past year. The regulatory landscape remains fragmented, with some states banning specific cannabinoids while others implement testing and labeling requirements.
The federal ban on synthetic hemp products, announced earlier this year, gave state lawmakers political cover to act. But implementation timelines remain unclear at both levels of government.
For Indiana's hemp retailers, the new restrictions could mean significant business model changes. Some may pivot to CBD-only products, while others could face closure if intoxicating hemp sales represented their primary revenue.
The legislation represents a broader trend of states reasserting control over hemp markets that exploded faster than regulators anticipated. Whether Indiana eventually moves toward comprehensive cannabis legalization—as neighboring Illinois and Michigan have done—remains an open question.
This article is based on original reporting by www.marijuanamoment.net.
Original Source
This article is based on reporting from Marijuana Moment.
Read the original articleOriginal title: "Indiana Lawmakers Approve Bill To Restrict And Regulate Hemp THC Products"
Related Topics
Related Stories
LegislationConnecticut Expands Psychedelics Pilot as FDA Decision Looms
Connecticut's Joint Committee on Public Health advanced legislation expanding the state's psychedelic therapy pilot program to include first responders, as lawmakers prepare for potential FDA approval of MDMA and psilocybin treatments.
LegislationRescheduling Won't Fix Cannabis Industry Without Insurance Access
Cannabis industry experts argue Trump's rescheduling order won't stabilize the market without insurance reimbursement access, which matters more than tax relief for long-term viability.
LegislationVirginia Moves Closer to Legal Cannabis Sales as Bills Advance
Virginia's House and Senate advanced companion bills to legalize cannabis sales, moving the legislation closer to Governor Youngkin's desk despite his previous opposition.
More from David Okonkwo
View all articles
Connecticut Expands Psychedelics Pilot as FDA Decision Looms

Virginia Moves Closer to Legal Cannabis Sales After House, Senate Votes

California Cannabis Packaging Rules Face Industry Scrutiny

